Abstract
Crosstalk between cardiac cells is critical for heart performance. Here we show that vascular cells within human cardiac organoids (hCOs) enhance their maturation, force of contraction, and utility in disease modeling. Herein we optimize our protocol to generate vascular populations in addition to epicardial, fibroblast, and cardiomyocyte cells that self-organize into in-vivo-like structures in hCOs. We identify mechanisms of communication between endothelial cells, pericytes, fibroblasts, and cardiomyocytes that ultimately contribute to cardiac organoid maturation. In particular, (1) endothelial-derived LAMA5 regulates expression of mature sarcomeric proteins and contractility, and (2) paracrine platelet-derived growth factor receptor β (PDGFRβ) signaling from vascular cells upregulates matrix deposition to augment hCO contractile force. Finally, we demonstrate that vascular cells determine the magnitude of diastolic dysfunction caused by inflammatory factors and identify a paracrine role of endothelin driving dysfunction. Together this study highlights the importance and role of vascular cells in organoid models.
Original language | English |
---|---|
Article number | 112322 |
Number of pages | 22 |
Journal | Cell Reports |
Volume | 42 |
Issue number | 5 |
DOIs | |
Publication status | Published - 30 May 2023 |
Keywords
- cardiac organoid
- CP: Stem cell research
- disease modeling
- endothelial cells
- endothelin-1
- extracellular matrix
- inflammation
- LAMA5
- PDGF
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Cell Reports, Vol. 42, No. 5, 112322, 30.05.2023.
Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Vascular cells improve functionality of human cardiac organoids
AU - Voges, Holly K.
AU - Foster, Simon
AU - Reynolds, Liam T.
AU - Parker, Benjamin L
AU - Devilee, Lynn
AU - Quaife-Ryan, Gregory A.
AU - Fortuna, Patrick R.J.
AU - Mathieson, Ellen
AU - Fitzsimmons, Rebecca
AU - Lor, Mary
AU - Batho, Christopher
AU - Reid, Janice
AU - Pocock, Mark
AU - Friedmand, Clayton E.
AU - Mizikovsky, Dalia
AU - Francois, Mathias
AU - Palpant, Nathan J.
AU - Needham, Elise J.
AU - Peralta, Marina
AU - del Monte Nieto, Gonzalo
AU - Jones, Lynelle K.
AU - Smyth, Ian M.
AU - Mehdiabadi, Neda R.
AU - Bolk, Francesca
AU - Janbandhu, Vaibhao
AU - Yao, Ernestene
AU - Harvey, Richard P.
AU - Chong, James J.H.
AU - Elliott, David A.
AU - Stanley, Edouard G.
AU - Wiszniak, Sophie
AU - Schwarz, Quenten
AU - James, David E.
AU - Mills, Richard J.
AU - Porrello, Enzo R.
AU - Hudson, James E.
N1 - Funding Information: We acknowledge grant and fellowship support from the National Health and Medical Research Council of Australia (R.P.H., E.R.P., and J.E.H.), Heart Foundation of Australia (G.d.M.-N., J.J.H.C., E.R.P., and J.E.H.), QIMR Berghofer Medical Research Institute (J.E.H.), The Stafford Fox Foundation (E.R.P.), the Royal Children's Hospital Foundation (E.R.P.), Foundation Leducq Transatlantic Network of Excellence in Cardiovascular Research (R.P.H. and V.J.), Australian Research Council Strategic Initiative in Stem Cell Science (Stem Cells Australia) (R.P.H., V.J., E.R.P., and J.E.H.), and the Victor Chang Cardiac Research Institute Innovation Centre (funded by the New South Wales Government Ministry of Health ) and Queensland Health (J.E.H.). The Novo Nordisk Foundation Center for Stem Cell Medicine (R.J.M., E.R.P., D.A.E., and E.G.S.) is supported by Novo Nordisk Foundation grants ( NNF21CC0073729 ). The Murdoch Children’s Research Institute is supported by the Victorian Government’s Operational Infrastructure Support Program . Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. J.E.H. is supported by a Snow Medical Fellowship . Funding Information: We used the Australian National Fabrication Facility Queensland Node for the fabrication of the Heart-Dyno molds. WTC CRISPRi GCaMP hiPSCs (Karyotype: 46, XY; RRID CVCL_VM38) generously provided by M. Mandegar and B. Conklin (UCSF, Gladstone Institute). We thank Grace Chojnowski and Michael Rist for FACS at QIMR Berghofer and Geoff Osborne and Virginia Nink for FACS at The University of Queensland. Microscopy was aided by Tam Nguyen and Nigel Waterhouse at QIMR Berghofer and Carsten Minten and Taryn Gulnan from Leica. We acknowledge grant and fellowship support from the National Health and Medical Research Council of Australia (R.P.H. E.R.P. and J.E.H.), Heart Foundation of Australia (G.d.M.-N. J.J.H.C. E.R.P. and J.E.H.), QIMR Berghofer Medical Research Institute (J.E.H.), The Stafford Fox Foundation (E.R.P.), the Royal Children's Hospital Foundation (E.R.P.), Foundation Leducq Transatlantic Network of Excellence in Cardiovascular Research (R.P.H. and V.J.), Australian Research Council Strategic Initiative in Stem Cell Science (Stem Cells Australia) (R.P.H. V.J. E.R.P. and J.E.H.), and the Victor Chang Cardiac Research Institute Innovation Centre (funded by the New South Wales Government Ministry of Health) and Queensland Health (J.E.H.). The Novo Nordisk Foundation Center for Stem Cell Medicine (R.J.M. E.R.P. D.A.E. and E.G.S.) is supported by Novo Nordisk Foundation grants (NNF21CC0073729). The Murdoch Children's Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program. Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. J.E.H. is supported by a Snow Medical Fellowship. H.K.V. R.J.M. E.R.P. and J.E.H. designed the experiment(s). D.A.E. L.J. I.S. C.E.F. N.P. and E.S. provided reagents. H.K.V. S.R.F. L.D. L.R. G.A.Q.-R. V.J. E.Y. M.L. C.B. R.F. M.P. S.W. P.F. E.M. S.R.F. B.L.P. E.N. and J.E.H. conducted experiments. H.K.V. S.R.F. L.R. L.D. R.P.H. V.J. N.R.M. G.A.Q.-R. J.J.H.C. M.F. F.B. G.d.M.-N. I.S. Q.S. N.P. D.E.J. R.J.M. E.R.P. and J.E.H. analyzed the results. H.K.V. E.R.P. and J.E.H. wrote the manuscript. All authors reviewed and approved the manuscript. R.J.M. J.E.H. G.A.Q.-R. and E.R.P. are listed as co-inventors on pending patents that relate to cardiac organoid maturation and cardiac regeneration therapeutics. E.R.P. and J.E.H. are listed as co-inventors on pending patents that relate to endothelial cells in 3D cardiac products. J.E.H. is a co-inventor on licensed patents relating to engineered heart muscle. R.J.M. E.R.P. and J.E.H. are co-founders, scientific advisors, and stockholders in Dynomics. Publisher Copyright: © 2023 The Author(s)
PY - 2023/5/30
Y1 - 2023/5/30
N2 - Crosstalk between cardiac cells is critical for heart performance. Here we show that vascular cells within human cardiac organoids (hCOs) enhance their maturation, force of contraction, and utility in disease modeling. Herein we optimize our protocol to generate vascular populations in addition to epicardial, fibroblast, and cardiomyocyte cells that self-organize into in-vivo-like structures in hCOs. We identify mechanisms of communication between endothelial cells, pericytes, fibroblasts, and cardiomyocytes that ultimately contribute to cardiac organoid maturation. In particular, (1) endothelial-derived LAMA5 regulates expression of mature sarcomeric proteins and contractility, and (2) paracrine platelet-derived growth factor receptor β (PDGFRβ) signaling from vascular cells upregulates matrix deposition to augment hCO contractile force. Finally, we demonstrate that vascular cells determine the magnitude of diastolic dysfunction caused by inflammatory factors and identify a paracrine role of endothelin driving dysfunction. Together this study highlights the importance and role of vascular cells in organoid models.
AB - Crosstalk between cardiac cells is critical for heart performance. Here we show that vascular cells within human cardiac organoids (hCOs) enhance their maturation, force of contraction, and utility in disease modeling. Herein we optimize our protocol to generate vascular populations in addition to epicardial, fibroblast, and cardiomyocyte cells that self-organize into in-vivo-like structures in hCOs. We identify mechanisms of communication between endothelial cells, pericytes, fibroblasts, and cardiomyocytes that ultimately contribute to cardiac organoid maturation. In particular, (1) endothelial-derived LAMA5 regulates expression of mature sarcomeric proteins and contractility, and (2) paracrine platelet-derived growth factor receptor β (PDGFRβ) signaling from vascular cells upregulates matrix deposition to augment hCO contractile force. Finally, we demonstrate that vascular cells determine the magnitude of diastolic dysfunction caused by inflammatory factors and identify a paracrine role of endothelin driving dysfunction. Together this study highlights the importance and role of vascular cells in organoid models.
KW - cardiac organoid
KW - CP: Stem cell research
KW - disease modeling
KW - endothelial cells
KW - endothelin-1
KW - extracellular matrix
KW - inflammation
KW - LAMA5
KW - PDGF
UR - http://www.scopus.com/inward/record.url?scp=85160394968&partnerID=8YFLogxK
U2 - 10.1016/j.celrep.2023.112322
DO - 10.1016/j.celrep.2023.112322
M3 - Article
C2 - 37105170
AN - SCOPUS:85160394968
SN - 2211-1247
VL - 42
JO - Cell Reports
JF - Cell Reports
IS - 5
M1 - 112322
ER -